» Articles » PMID: 35803367

Inflammation in Kidney Repair: Mechanism and Therapeutic Potential

Overview
Journal Pharmacol Ther
Specialty Pharmacology
Date 2022 Jul 8
PMID 35803367
Authors
Affiliations
Soon will be listed here.
Abstract

The kidney has a remarkable ability of repair after acute kidney injury (AKI). However, when injury is severe or persistent, the repair is incomplete or maladaptive and may lead to chronic kidney disease (CKD). Maladaptive kidney repair involves multiple cell types and multifactorial processes, of which inflammation is a key component. In the process of inflammation, there is a bidirectional interplay between kidney parenchymal cells and the immune system. The extensive and complex crosstalk between renal tubular epithelial cells and interstitial cells, including immune cells, fibroblasts, and endothelial cells, governs the repair and recovery of the injured kidney. Further research in this field is imperative for the discovery of biomarkers and promising therapeutic targets for kidney repair. In this review, we summarize the latest progress in the immune response and inflammation during maladaptive kidney repair, analyzing the interaction between immune cells and intrinsic kidney cells, pointing out the potentialities of inflammation-related pathways as therapeutic targets, and discussing the challenges and future research prospects in this field.

Citing Articles

Bioinformatics analysis of the expression of potential common genes and immune-related genes between atrial fibrillation and chronic kidney disease.

Teng J, Deng G Front Cardiovasc Med. 2025; 12:1521722.

PMID: 40078458 PMC: 11897265. DOI: 10.3389/fcvm.2025.1521722.


Exosomes secreted by ATF3/Nrf2-mediated ferroptotic renal tubular epithelial cells promote M1/M2 ratio imbalance inducing renal interstitial fibrosis following ischemia and reperfusion injury.

Tang Q, Xie J, Wang Y, Dong C, Sun Q Front Immunol. 2025; 16:1510500.

PMID: 39975560 PMC: 11835872. DOI: 10.3389/fimmu.2025.1510500.


Salivary proteomics profiling reveals potential biomarkers for chronic kidney disease: a pilot study.

Picolo B, Silva N, Martins M, Almeida-Souza H, de Sousa L, Polveiro R Front Med (Lausanne). 2025; 11:1302637.

PMID: 39895822 PMC: 11784343. DOI: 10.3389/fmed.2024.1302637.


Unraveling Ferroptosis: A New Frontier in Combating Renal Fibrosis and CKD Progression.

Jin R, Dai Y, Wang Z, Hu Q, Zhang C, Gao H Biology (Basel). 2025; 14(1).

PMID: 39857243 PMC: 11763183. DOI: 10.3390/biology14010012.


Utility of plasma suPAR to identify AKI and sepsis associated AKI in critically ill children.

Xu J, Chen J, Li M, Jiang Z, Fang F, Hu J iScience. 2024; 27(11):111247.

PMID: 39569376 PMC: 11576388. DOI: 10.1016/j.isci.2024.111247.